梅宁抑制剂有望作为白血病最新靶向疗法首次亮相

IF 12.6 1区医学 Q1 ALLERGY

Allergy Pub Date : 2024-06-21 DOI:10.1038/d41573-024-00106-3

Ken Garber

引用次数: 0

摘要

阻断关键蛋白-蛋白相互作用的小分子药物可能会改变许多急性白血病患者的治疗前景。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Menin inhibitors seek to debut as newest targeted therapy for leukaemia

查看原文本刊更多论文

Menin inhibitors seek to debut as newest targeted therapy for leukaemia

Small molecules that block a key protein–protein interaction could change the treatment landscape for many patients with acute leukaemias. Small molecules that block a key protein–protein interaction could change the treatment landscape for many patients with acute leukaemias.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Allergy 医学-过敏

CiteScore

26.10

自引率

9.70%

发文量

393

审稿时长

2 months

期刊介绍： Allergy is an international and multidisciplinary journal that aims to advance, impact, and communicate all aspects of the discipline of Allergy/Immunology. It publishes original articles, reviews, position papers, guidelines, editorials, news and commentaries, letters to the editors, and correspondences. The journal accepts articles based on their scientific merit and quality. Allergy seeks to maintain contact between basic and clinical Allergy/Immunology and encourages contributions from contributors and readers from all countries. In addition to its publication, Allergy also provides abstracting and indexing information. Some of the databases that include Allergy abstracts are Abstracts on Hygiene & Communicable Disease, Academic Search Alumni Edition, AgBiotech News & Information, AGRICOLA Database, Biological Abstracts, PubMed Dietary Supplement Subset, and Global Health, among others.